| scholarly article | Q13442814 |
| P50 | author | Yves Agid | Q3573439 |
| Alexis Brice | Q28468841 | ||
| Bruno Dubois | Q33102860 | ||
| Sophie Tezenas du Montcel | Q39898770 | ||
| French Parkinson's Disease Genetics Study Group | Q63143946 | ||
| Stephane Thobois | Q64856218 | ||
| Emmanuel Broussolle | Q67218064 | ||
| P2093 | author name string | L Mallet | |
| P Pollak | |||
| P Remy | |||
| E Lohmann | |||
| S Lesage | |||
| A Pelissolo | |||
| M-J Ribeiro | |||
| P2860 | cites work | Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism | Q24309753 |
| Chromosome 6-linked autosomal recessive early-onset Parkinsonism: linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family. The French Parkinson's Disease Genetics Study | Q24539105 | ||
| Association between early-onset Parkinson's disease and mutations in the parkin gene | Q29615733 | ||
| Proposed dose equivalence for rapid switch between dopamine receptor agonists in Parkinson's disease: a review of the literature | Q33234388 | ||
| Alpha-synuclein and Parkinson's disease | Q34160107 | ||
| How much phenotypic variation can be attributed to parkin genotype? | Q34218728 | ||
| Deletion of the parkin and PACRG gene promoter in early-onset parkinsonism | Q34577165 | ||
| Complex relationship between Parkin mutations and Parkinson disease | Q34737305 | ||
| Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. | Q36834550 | ||
| Deciphering the role of heterozygous mutations in genes associated with parkinsonism | Q36854642 | ||
| Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations | Q44125029 | ||
| Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study | Q44147105 | ||
| Parkin disease: a phenotypic study of a large case series | Q44451919 | ||
| Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism | Q44848194 | ||
| Parkin mutations are frequent in patients with isolated early-onset parkinsonism | Q48245134 | ||
| Dopa-responsive dystonia: [18F]dopa positron emission tomography | Q48702850 | ||
| Autosomal recessive early-onset parkinsonism with diurnal fluctuation: clinicopathologic characteristics and molecular genetic identification | Q48714145 | ||
| The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations | Q48829560 | ||
| Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene | Q48944767 | ||
| Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. | Q67242933 | ||
| Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease | Q73944220 | ||
| Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls | Q80980652 | ||
| Parkin disease in a Brazilian kindred: Manifesting heterozygotes and clinical follow-up over 10 years | Q81248024 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 110-116 | |
| P577 | publication date | 2008-11-05 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | A multidisciplinary study of patients with early-onset PD with and without parkin mutations | |
| P478 | volume | 72 |
| Q57646317 | A Case of Parkinson's Disease with No Lewy Body Pathology due to a Homozygous Exon Deletion in |
| Q35924508 | A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics |
| Q37862761 | A Précis of Recent Advances in the Neuropsychology of Mild Cognitive Impairment(s) in Parkinson's Disease and a Proposal of Preliminary Research Criteria |
| Q34597756 | A meta-analysis of the relationship of the Parkin p.Val380Leu polymorphism to Parkinson's disease. |
| Q50262605 | A young adult with progressive limb shaking and slowness |
| Q35078309 | Altered hippocampal synaptic physiology in aged parkin-deficient mice |
| Q36176035 | Brain Connectivity Changes in Autosomal Recessive Parkinson Disease: A Model for the Sporadic Form |
| Q36169215 | CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report |
| Q37625797 | Cognitive and motor function in long-duration PARKIN-associated Parkinson disease |
| Q47860019 | Cognitive changes in prodromal Parkinson's disease: A review |
| Q64118674 | Early Dyskinesias in Parkinson's Disease Patients With Parkin Mutation: A Primary Corticostriatal Synaptopathy? |
| Q92035991 | Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study |
| Q53091543 | Lack of association between p.Ser167Asn variant of Parkin and Parkinson's disease: a meta-analysis of 15 studies involving 2,280 cases and 2,459 controls |
| Q38038561 | Lysosome-dependent pathways as a unifying theme in Parkinson's disease. |
| Q33960440 | Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines |
| Q47902700 | Mutation analysis of sporadic early-onset Alzheimer's disease using the NeuroX array |
| Q39119095 | Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease. |
| Q36005602 | Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study |
| Q45900021 | Nonmotor symptoms in Parkin gene-related parkinsonism. |
| Q42696784 | Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease |
| Q52559939 | Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process. |
| Q38254117 | Parkinson's disease: chameleons and mimics |
| Q44244839 | Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations |
| Q30249553 | Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management |
| Q42010008 | Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease |
| Q30357944 | The Monoamine Brainstem Reticular Formation as a Paradigm for Re-Defining Various Phenotypes of Parkinson's Disease Owing Genetic and Anatomical Specificity. |
| Q35566358 | The relation between depression and parkin genotype: the CORE-PD study |
| Q35054613 | The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study |
| Q37685691 | Treatment of young-onset Parkinson's disease: role of dopamine receptor agonists |
| Q36372732 | Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease |
| Q87782484 | Variable phenotypic expression in families with early-onset Parkinsonism due to PRKN mutations |
| Q37930020 | l-Dopa-Induced Dyskinesia—Clinical Presentation, Genetics, and Treatment |
Search more.